Description
UK 370106 inhibits MMPs, enzymes that degrade extracellular matrix components, thus having potential therapeutic applications in cancer and chronic inflammatory diseases. It targets MMP-12, MMP-13, MMP-14, MMP-2, MMP-3, MMP-7, MMP-8, and MMP-9.
Applications
UK 370106 is relevant to cancer research, targeting enzymes responsible for extracellular matrix breakdown, important in metastasis inhibition.